MedTrace Logo

myoActivation® for Chronic Pain in a Marginalized Population

NCT04261959 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 41

Last updated 2025-09-16

No results posted yet for this study

Summary

Marginalized populations are at increased risk of chronic pain, trauma and use of street drugs to manage this suffering, with the associated risk of overdoses. Non-pharmacological options to manage chronic pain are difficult for this population to access. myoActivation® is an innovative structured assessment and therapeutic approach. This study will be conducted in the Vancouver Community Pain Service and will will examine the impact of this treatment on pain outcomes, function and quality of life.

Conditions

  • Pain, Chronic
  • Widespread Chronic Pain

Interventions

OTHER

myoActivation

myoActivation is a novel, structured assessment and non-pharmacological therapeutic approach to both diagnosis and treatment of chronic myofascial pain. A detailed history of the timeline of lifetime trauma combined with a quick, structured and reproducible set of posture and movement tests help to easily identify myofascial components of chronic pain. The therapeutic component is delivered utilizing a needling technique, or myofascial release, focused to active myofascial trigger points, fascia in tension and tethered scars.

Sponsors & Collaborators

  • Vancouver Coastal Health Research Institute

    collaborator OTHER

  • BC Children's Hospital Research Institute

    collaborator OTHER

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Barbara Eddy · Vancouver Coastal Health

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-18
Primary Completion
2022-08-02
Completion
2022-08-02

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04261959 on ClinicalTrials.gov